Linde India Ltd (BSE: 523457) is a Kolkata, West Bengal-based company in the Industrial & Medical Gases industry. With a market capitalisation of ₹58,003 Cr, it ranks #187 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 8 in Industrial & Medical Gases. At ₹6,734.00 (as of 19 Nov 2026), the share price is 16.3% below its 52-week high of ₹8,049.00 and 21.5% above its 52-week low of ₹5,544.00. The share price is up 16.1% over one year and up 0.5% over three months.
| Current Price | ₹6,734.00 |
|---|---|
| Market Cap | ₹58,003 Cr |
| BSE Code | 523457 |
| Sector | Materials > Chemicals > Gases |
| Sub-Industry | Industrial & Medical Gases |
| P/E Ratio | 106.1 |
| Return on Equity | 13.58% |
| Return on Assets | 7.76% |
| 52-Week Range | ₹5,544.00 – ₹8,049.00 |
| 1-Year Price Change | +16.1% |
| 3-Month Price Change | +0.5% |
| Beta (1Y) | 0.07 |
| Dividend Yield | 0.06% |
| Headquarters | Kolkata, West Bengal |
| Website | www.linde.in |
| Revenue | ₹723 Cr |
|---|---|
| Net Profit | ₹119 Cr |
| Net Margin | 16.4% |
| EPS (Basic) | ₹13.93 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Linde India Ltd reported revenue of ₹723 Cr in Q2 FY27, up 12.3% from ₹644 Cr in Q2 FY26 and up 4.2% from ₹694 Cr in Q1 FY27. It posted a net profit of ₹119 Cr for the quarter, against a net profit of ₹171 Cr in Q2 FY26 (down 30.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹571 Cr (Q1 FY26) to ₹723 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹723 Cr | ₹119 Cr | 16.4% |
| Q1 FY27 | ₹694 Cr | ₹105 Cr | 15.1% |
| Q4 FY26 | ₹614 Cr | ₹77 Cr | 12.6% |
| Q3 FY26 | ₹701 Cr | ₹193 Cr | 27.6% |
| Q2 FY26 | ₹644 Cr | ₹171 Cr | 26.5% |
| Q1 FY26 | ₹571 Cr | ₹107 Cr | 18.8% |
| Q4 FY25 | ₹592 Cr | ₹118 Cr | 20.0% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 75.00% of Linde India Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 45.6% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).
Linde India Limited manufactures and sells industrial and medical gases in India. It operates through Gases, Related Products and Services; and Project Engineering Division segments. The Gases, Related Products and Services segment produces and sells oxygen, nitrogen, and argon gases. This segment engages in the provision of pipeline gas supply to steel, glass, and chemical industries; liquefied gases through cryogenic tankers to various industrial sectors; and compressed gas in cylinders to fabrication, manufacturing, and construction industries. It offers gases, such as medical oxygen, synthetic air, and nitrous oxide for pharmaceutical use, as well as medical gas distribution systems to hospitals. The Project Engineering Division is involved in the design, engineering, manufacture, and commissioning of cryogenic and non-cryogenic air separation plants (ASUs), vacuum pressure swing adsorption (VPSA) units, and nitrogen plants; and the sale of distillation columns, cryogenic storage t
1. Gases and Related Products-This segment produces gases, such as oxygen, nitrogen, and argon. It offers pipeline gas supplies to industrial customers; supplies liquefied gases through cryogenic tankers to a range of industrial sectors; and compressed gas supply in cylinders. 2. Project Engineering-This segment is involved in the design, engineering, supply, installation, testing, and commissioning of air separation plants and related projects on turnkey basis. 3. Inter Segment Elimination-0 4. Unallocated-0
1. Gases, Related Products & Services-84.1% 2. Project Engineering-38.7%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Linde India Ltd | ₹58,003 Cr | 106.1 | 13.58% | ₹723 Cr | +16.1% |
| Ellenbarrie Industrial Gases Limited | ₹4,139 Cr | 39.3 | 10.68% | ₹114 Cr | -37.8% |
| Steamhouse India Limited | ₹4,002 Cr | 88.7 | — | ₹128 Cr | — |
| Stallion India Fluorochemicals Limited | ₹2,348 Cr | 36.9 | 8.93% | ₹136 Cr | -19.2% |
| Hilltone Software and Gases Ltd | ₹51 Cr | — | — | — | -51.8% |
| National Oxygen Ltd. | ₹29 Cr | 16.8 | -26.02% | — | -48.8% |
| Bhagwati Oxygen Ltd | ₹9 Cr | 2.9 | 58.24% | — | -16.2% |
| The Southern Gas Limited | ₹0 Cr | 0 | — | — | 0.0% |
Listed by market capitalisation. Ratios are shown for context only.
Linde India Ltd is trading at ₹6,734.00, with a market capitalisation of ₹58,003 Cr.
Linde India Ltd operates in the Materials > Chemicals > Gases space (Industrial & Medical Gases).
Linde India Ltd has a P/E of 106.1 and a return on equity of 13.58%.
Linde India Ltd is listed on the BSE under the scrip code 523457.
Linde India Ltd's share price is up 16.1% over one year and up 0.5% over three months. Its 52-week range is ₹5,544.00 to ₹8,049.00.
In Q2 FY27, Linde India Ltd reported revenue of ₹723 Cr and net profit of ₹119 Cr, with basic EPS of ₹13.93 (consolidated, parsed from the company's exchange filing).
Linde India Ltd reported revenue of ₹723 Cr in Q2 FY27, up 12.3% from ₹644 Cr in Q2 FY26 and up 4.2% from ₹694 Cr in Q1 FY27.
Promoters held 75.00% of Linde India Ltd's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.